Plain-English translation of NCT07063901 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing an artificial intelligence tool to predict how well patients with esophageal cancer will respond to chemotherapy and immunotherapy before they have surgery. The study collects medical information—including imaging scans, blood tests, and pathology results—from patients receiving this type of treatment. The goal is to help doctors identify early which patients are responding well and which may need a different approach.
Currently, doctors cannot always predict before surgery which patients will have a complete response to chemotherapy and immunotherapy. By using artificial intelligence to analyze all of a patient's medical data together, researchers hope to catch patients who aren't responding well much earlier, so treatment plans can be adjusted if needed.
You likely qualify if…
You likely don't qualify if…
You would allow researchers to access and analyze your medical records, imaging scans, and laboratory results from before and after your chemotherapy and immunotherapy treatment. This is an observational study, meaning you would not receive any new medication or procedures—researchers would simply review the information you've already had collected as part of your regular cancer care. The study aims to enroll 200 patients and is currently recruiting.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
China